Filed: 8/14/2024ACC: 0001172661-24-003577
📋 What this filing means
GREAT POINT PARTNERS LLC filed this quarterly 13F‑HR report disclosing 33 equity positions with a total reported market value of $522.02M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
33
Positions
$522.02M
Total AUM (reported)
65.83M
Total Shares
Allocation by class
COM$347.40M66.6%
COM NEW$64.69M12.4%
SPONSORED ADS$32.68M6.3%
COMMON STOCK$27.15M5.2%
COM PAR $.01$16.75M3.2%
CLASS A ORD SHS$16.25M3.1%
SPON ADS$11.98M2.3%
Portfolio Concentration
Top 3$118.00M22.6%
4–10$185.03M35.4%
11–25$190.62M36.5%
Rest$28.37M5.4%
Top 3 weight
22.6%
Top 10 weight
58.0%
Voting Authority Distribution
Total shares with voting rights: 65.83M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
65.83M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other33
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings33
Rows:
UROGEN PHARMA LTD
DFNDShares2.91M
TypeSH
Market value$48.77M
9.34%
Sole
0.00
Shared
2.91M
None
0.00
NEUROGENE INC
DFNDShares1M
TypeSH
Market value$36.55M
7.00%
Sole
0.00
Shared
1M
None
0.00
ABIVAX SA
DFNDShares2.47M
TypeSH
Market value$32.68M
6.26%
Sole
0.00
Shared
2.47M
None
0.00
MERUS N V
DFNDShares523.29K
TypeSH
Market value$30.96M
5.93%
Sole
0.00
Shared
523.29K
None
0.00
PLIANT THERAPEUTICS INC
DFNDShares2.64M
TypeSH
Market value$28.35M
5.43%
Sole
0.00
Shared
2.64M
None
0.00
ARCELLX INC
DFNDShares492K
TypeSH
Market value$27.15M
5.20%
Sole
0.00
Shared
492K
None
0.00
DYNAVAX TECHNOLOGIES CORP
DFNDShares2.37M
TypeSH
Market value$26.66M
5.11%
Sole
0.00
Shared
2.37M
None
0.00
EVOLUS INC
DFNDShares2.45M
TypeSH
Market value$26.60M
5.10%
Sole
0.00
Shared
2.45M
None
0.00
CYTOKINETICS INC
DFNDShares474.20K
TypeSH
Market value$25.69M
4.92%
Sole
0.00
Shared
474.20K
None
0.00
DIANTHUS THERAPEUTICS INC
DFNDShares757.93K
TypeSH
Market value$19.62M
3.76%
Sole
0.00
Shared
757.93K
None
0.00
INSMED INC
DFNDShares250K
TypeSH
Market value$16.75M
3.21%
Sole
0.00
Shared
250K
None
0.00
ZURA BIO LTD
DFNDShares4.64M
TypeSH
Market value$16.25M
3.11%
Sole
0.00
Shared
4.64M
None
0.00
KALVISTA PHARMACEUTICALS INC
DFNDShares1.34M
TypeSH
Market value$15.77M
3.02%
Sole
0.00
Shared
1.34M
None
0.00
IONIS PHARMACEUTICALS INC
DFNDShares330K
TypeSH
Market value$15.73M
3.01%
Sole
0.00
Shared
330K
None
0.00
CONTEXT THERAPEUTICS INC
DFNDShares7.42M
TypeSH
Market value$14.88M
2.85%
Sole
0.00
Shared
7.42M
None
0.00
AMICUS THERAPEUTICS INC
DFNDShares1.50M
TypeSH
Market value$14.84M
2.84%
Sole
0.00
Shared
1.50M
None
0.00
OPTINOSE INC
DFNDShares13.73M
TypeSH
Market value$14.28M
2.73%
Sole
0.00
Shared
13.73M
None
0.00
ESPERION THERAPEUTICS INC NE
DFNDShares5.79M
TypeSH
Market value$12.86M
2.46%
Sole
0.00
Shared
5.79M
None
0.00
VOYAGER THERAPEUTICS INC
DFNDShares1.60M
TypeSH
Market value$12.67M
2.43%
Sole
0.00
Shared
1.60M
None
0.00
OUTLOOK THERAPEUTICS INC
DFNDShares1.70M
TypeSH
Market value$12.56M
2.41%
Sole
0.00
Shared
1.70M
None
0.00
AUTOLUS THERAPEUTICS PLC
DFNDShares3.44M
TypeSH
Market value$11.98M
2.29%
Sole
0.00
Shared
3.44M
None
0.00
JASPER THERAPEUTICS INC
DFNDShares402.01K
TypeSH
Market value$9.13M
1.75%
Sole
0.00
Shared
402.01K
None
0.00
OLEMA PHARMACEUTICALS INC
DFNDShares796.88K
TypeSH
Market value$8.62M
1.65%
Sole
0.00
Shared
796.88K
None
0.00
TERNS PHARMACEUTICALS INC
DFNDShares1.15M
TypeSH
Market value$7.83M
1.50%
Sole
0.00
Shared
1.15M
None
0.00
VIRIDIAN THERAPEUTICS INC
DFNDShares500K
TypeSH
Market value$6.50M
1.25%
Sole
0.00
Shared
500K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
UROGEN PHARMA LTDDFND | COM | 2.91M | SH | $48.77M 9.34% | 0.00 | 2.91M | 0.00 |
NEUROGENE INCDFND | COM | 1M | SH | $36.55M 7.00% | 0.00 | 1M | 0.00 |
ABIVAX SADFND | SPONSORED ADS | 2.47M | SH | $32.68M 6.26% | 0.00 | 2.47M | 0.00 |
MERUS N VDFND | COM | 523.29K | SH | $30.96M 5.93% | 0.00 | 523.29K | 0.00 |
PLIANT THERAPEUTICS INCDFND | COM | 2.64M | SH | $28.35M 5.43% | 0.00 | 2.64M | 0.00 |
ARCELLX INCDFND | COMMON STOCK | 492K | SH | $27.15M 5.20% | 0.00 | 492K | 0.00 |
DYNAVAX TECHNOLOGIES CORPDFND | COM NEW | 2.37M | SH | $26.66M 5.11% | 0.00 | 2.37M | 0.00 |
EVOLUS INCDFND | COM | 2.45M | SH | $26.60M 5.10% | 0.00 | 2.45M | 0.00 |
CYTOKINETICS INCDFND | COM NEW | 474.20K | SH | $25.69M 4.92% | 0.00 | 474.20K | 0.00 |
DIANTHUS THERAPEUTICS INCDFND | COM | 757.93K | SH | $19.62M 3.76% | 0.00 | 757.93K | 0.00 |
INSMED INCDFND | COM PAR $.01 | 250K | SH | $16.75M 3.21% | 0.00 | 250K | 0.00 |
ZURA BIO LTDDFND | CLASS A ORD SHS | 4.64M | SH | $16.25M 3.11% | 0.00 | 4.64M | 0.00 |
KALVISTA PHARMACEUTICALS INCDFND | COM | 1.34M | SH | $15.77M 3.02% | 0.00 | 1.34M | 0.00 |
IONIS PHARMACEUTICALS INCDFND | COM | 330K | SH | $15.73M 3.01% | 0.00 | 330K | 0.00 |
CONTEXT THERAPEUTICS INCDFND | COM | 7.42M | SH | $14.88M 2.85% | 0.00 | 7.42M | 0.00 |
AMICUS THERAPEUTICS INCDFND | COM | 1.50M | SH | $14.84M 2.84% | 0.00 | 1.50M | 0.00 |
OPTINOSE INCDFND | COM | 13.73M | SH | $14.28M 2.73% | 0.00 | 13.73M | 0.00 |
ESPERION THERAPEUTICS INC NEDFND | COM | 5.79M | SH | $12.86M 2.46% | 0.00 | 5.79M | 0.00 |
VOYAGER THERAPEUTICS INCDFND | COM | 1.60M | SH | $12.67M 2.43% | 0.00 | 1.60M | 0.00 |
OUTLOOK THERAPEUTICS INCDFND | COM | 1.70M | SH | $12.56M 2.41% | 0.00 | 1.70M | 0.00 |
AUTOLUS THERAPEUTICS PLCDFND | SPON ADS | 3.44M | SH | $11.98M 2.29% | 0.00 | 3.44M | 0.00 |
JASPER THERAPEUTICS INCDFND | COM NEW | 402.01K | SH | $9.13M 1.75% | 0.00 | 402.01K | 0.00 |
OLEMA PHARMACEUTICALS INCDFND | COM | 796.88K | SH | $8.62M 1.65% | 0.00 | 796.88K | 0.00 |
TERNS PHARMACEUTICALS INCDFND | COM | 1.15M | SH | $7.83M 1.50% | 0.00 | 1.15M | 0.00 |
VIRIDIAN THERAPEUTICS INCDFND | COM | 500K | SH | $6.50M 1.25% | 0.00 | 500K | 0.00 |
Page 1 of 2